We're excited to welcome the Goodman Foundation as a community partner for our AllClear program, alongside principal partner the National Breast Cancer Foundation. 🔗 Read the full story: https://ow.ly/oufe5101yLR
#BreastCancerResearch #MedicalResearch
#BreastCancerResearch #MedicalResearch
October 28, 2026 at 12:37 AM
We're excited to welcome the Goodman Foundation as a community partner for our AllClear program, alongside principal partner the National Breast Cancer Foundation. 🔗 Read the full story: https://ow.ly/oufe5101yLR
#BreastCancerResearch #MedicalResearch
#BreastCancerResearch #MedicalResearch
There is still time to register for this #VirtualEvent on 10/30, hosted by the ASIP Breast Cancer SIG! Register now https://loom.ly/bOwUe1k
#BreastCancerAwarenessMonth #BreastCancerResearch
#BreastCancerAwarenessMonth #BreastCancerResearch
October 27, 2026 at 1:03 PM
There is still time to register for this #VirtualEvent on 10/30, hosted by the ASIP Breast Cancer SIG! Register now https://loom.ly/bOwUe1k
#BreastCancerAwarenessMonth #BreastCancerResearch
#BreastCancerAwarenessMonth #BreastCancerResearch
New findings from the FOURLIGHT-1 trial presented at #ESMO26 suggest atirmociclib plus Faslodex may help people with HR+, HER2-negative metastatic breast cancer live longer without the cancer growing.
Read more: https://bit.ly/4ewhPCh
#BreastCancer #BreastCancerResearch #InsightsbyESMO #Metavivor
Read more: https://bit.ly/4ewhPCh
#BreastCancer #BreastCancerResearch #InsightsbyESMO #Metavivor
October 25, 2026 at 10:21 PM
New findings from the FOURLIGHT-1 trial presented at #ESMO26 suggest atirmociclib plus Faslodex may help people with HR+, HER2-negative metastatic breast cancer live longer without the cancer growing.
Read more: https://bit.ly/4ewhPCh
#BreastCancer #BreastCancerResearch #InsightsbyESMO #Metavivor
Read more: https://bit.ly/4ewhPCh
#BreastCancer #BreastCancerResearch #InsightsbyESMO #Metavivor
@DFCI_BreastOnc is leading a trial on the use of #ColdCaps in preventing #HairLoss with novel #BreastCancer therapies, including sacituzumab, eribulin, or datopotamab deruxtecan. Contact us for info about the study or visit: dana-farber.org/clinical-tri... PI @esalehiDNP
#BreastCancerResearch
#BreastCancerResearch
October 26, 2026 at 1:27 PM
@DFCI_BreastOnc is leading a trial on the use of #ColdCaps in preventing #HairLoss with novel #BreastCancer therapies, including sacituzumab, eribulin, or datopotamab deruxtecan. Contact us for info about the study or visit: dana-farber.org/clinical-tri... PI @esalehiDNP
#BreastCancerResearch
#BreastCancerResearch
New results from the HEALER trial presented at #ESMO26 suggest anbenitamab plus HB1801 may help people with HER2-positive metastatic breast cancer live longer without the cancer growing. 🔗 https://bit.ly/4ewhPCh
#BreastCancer #BreastCancerResearch #InsightsbyESMO #BreastCancerTreatment
#BreastCancer #BreastCancerResearch #InsightsbyESMO #BreastCancerTreatment
October 26, 2026 at 1:18 AM
New results from the HEALER trial presented at #ESMO26 suggest anbenitamab plus HB1801 may help people with HER2-positive metastatic breast cancer live longer without the cancer growing. 🔗 https://bit.ly/4ewhPCh
#BreastCancer #BreastCancerResearch #InsightsbyESMO #BreastCancerTreatment
#BreastCancer #BreastCancerResearch #InsightsbyESMO #BreastCancerTreatment
New results from the HORIZON-Breast06 trial presented at #ESMO26 suggest trastuzumab rezetecan may help people with HER2-low metastatic breast cancer live longer without the cancer growing. https://bit.ly/4ewhPCh
#BreastCancer #BreastCancerResearch #InsightsbyESMO #BreastCancerTreatment
#BreastCancer #BreastCancerResearch #InsightsbyESMO #BreastCancerTreatment
October 26, 2026 at 12:20 AM
New results from the HORIZON-Breast06 trial presented at #ESMO26 suggest trastuzumab rezetecan may help people with HER2-low metastatic breast cancer live longer without the cancer growing. https://bit.ly/4ewhPCh
#BreastCancer #BreastCancerResearch #InsightsbyESMO #BreastCancerTreatment
#BreastCancer #BreastCancerResearch #InsightsbyESMO #BreastCancerTreatment
New results from the NATALEE trial presented at #ESMO26 suggest that adding Kisqali to an aromatase inhibitor may help people with early-stage HR+, HER2-negative #breastcancer live longer.
🔗Read more: https://bit.ly/4ewhPCh
#BreastCancerResearch #InsightsbyESMO #BreastCancerTreatment
🔗Read more: https://bit.ly/4ewhPCh
#BreastCancerResearch #InsightsbyESMO #BreastCancerTreatment
October 25, 2026 at 11:32 PM
New results from the NATALEE trial presented at #ESMO26 suggest that adding Kisqali to an aromatase inhibitor may help people with early-stage HR+, HER2-negative #breastcancer live longer.
🔗Read more: https://bit.ly/4ewhPCh
#BreastCancerResearch #InsightsbyESMO #BreastCancerTreatment
🔗Read more: https://bit.ly/4ewhPCh
#BreastCancerResearch #InsightsbyESMO #BreastCancerTreatment
New lidERA trial findings presented at #ESMO26 suggest giredestrant may be easier to tolerate than tamoxifen or aromatase inhibitors for early-stage HR+ #breastcancer.
Fewer people stopped treatment due to side effects (5% vs. 8%).
🔗 Read more:https://bit.ly/4ewhPCh
#BreastCancerResearch
Fewer people stopped treatment due to side effects (5% vs. 8%).
🔗 Read more:https://bit.ly/4ewhPCh
#BreastCancerResearch
October 25, 2026 at 8:33 PM
New lidERA trial findings presented at #ESMO26 suggest giredestrant may be easier to tolerate than tamoxifen or aromatase inhibitors for early-stage HR+ #breastcancer.
Fewer people stopped treatment due to side effects (5% vs. 8%).
🔗 Read more:https://bit.ly/4ewhPCh
#BreastCancerResearch
Fewer people stopped treatment due to side effects (5% vs. 8%).
🔗 Read more:https://bit.ly/4ewhPCh
#BreastCancerResearch
New breast cancer research is in the spotlight at ESMO 2026, with updates on treatments for early-stage and metastatic disease.
Explore this weekend’s highlights and what the findings could mean for breast cancer care. https://bit.ly/4ewhPCh
#ESMO2026 #ESMO26 #breastcancer #breastcancerresearch
Explore this weekend’s highlights and what the findings could mean for breast cancer care. https://bit.ly/4ewhPCh
#ESMO2026 #ESMO26 #breastcancer #breastcancerresearch
October 25, 2026 at 5:59 PM
New breast cancer research is in the spotlight at ESMO 2026, with updates on treatments for early-stage and metastatic disease.
Explore this weekend’s highlights and what the findings could mean for breast cancer care. https://bit.ly/4ewhPCh
#ESMO2026 #ESMO26 #breastcancer #breastcancerresearch
Explore this weekend’s highlights and what the findings could mean for breast cancer care. https://bit.ly/4ewhPCh
#ESMO2026 #ESMO26 #breastcancer #breastcancerresearch
🎀 This #PinkOctober, we stand with everyone affected by breast cancer. With 200+ screens and ~15 customer publications, we’re proud to support cancer research. Together, let’s raise awareness, encourage early detection, and advance science!💗
#BreastCancerAwareness #BreastCancerResearch
#BreastCancerAwareness #BreastCancerResearch
October 23, 2026 at 1:45 PM
🎀 This #PinkOctober, we stand with everyone affected by breast cancer. With 200+ screens and ~15 customer publications, we’re proud to support cancer research. Together, let’s raise awareness, encourage early detection, and advance science!💗
#BreastCancerAwareness #BreastCancerResearch
#BreastCancerAwareness #BreastCancerResearch
💗🎀 #WearItPink2026! 🎀💗
A huge thank you to everyone who took part, especially our shy colleagues who stepped out of their comfort zones! 🩷👏 We’re proud to support #BreastCancerNow in raising #awareness and funding vital #breastcancerresearch. #Togetherwecanmakeadifference! 💕
A huge thank you to everyone who took part, especially our shy colleagues who stepped out of their comfort zones! 🩷👏 We’re proud to support #BreastCancerNow in raising #awareness and funding vital #breastcancerresearch. #Togetherwecanmakeadifference! 💕
October 23, 2026 at 4:10 PM
💗🎀 #WearItPink2026! 🎀💗
A huge thank you to everyone who took part, especially our shy colleagues who stepped out of their comfort zones! 🩷👏 We’re proud to support #BreastCancerNow in raising #awareness and funding vital #breastcancerresearch. #Togetherwecanmakeadifference! 💕
A huge thank you to everyone who took part, especially our shy colleagues who stepped out of their comfort zones! 🩷👏 We’re proud to support #BreastCancerNow in raising #awareness and funding vital #breastcancerresearch. #Togetherwecanmakeadifference! 💕
🎀 IOR Pink Insights for #PinkOctober
💡 Myth or fact? - part 1
#PinkOctober #BreastCancerAwareness #BreastCancerResearch
💡 Myth or fact? - part 1
#PinkOctober #BreastCancerAwareness #BreastCancerResearch
October 21, 2026 at 3:24 PM
🎀 IOR Pink Insights for #PinkOctober
💡 Myth or fact? - part 1
#PinkOctober #BreastCancerAwareness #BreastCancerResearch
💡 Myth or fact? - part 1
#PinkOctober #BreastCancerAwareness #BreastCancerResearch
🎀 IOR Pink Insights for #PinkOctober
💡 Myth or fact? - part 2
#PinkOctober #BreastCancerAwareness #BreastCancerResearch
💡 Myth or fact? - part 2
#PinkOctober #BreastCancerAwareness #BreastCancerResearch
October 21, 2026 at 3:26 PM
🎀 IOR Pink Insights for #PinkOctober
💡 Myth or fact? - part 2
#PinkOctober #BreastCancerAwareness #BreastCancerResearch
💡 Myth or fact? - part 2
#PinkOctober #BreastCancerAwareness #BreastCancerResearch
🔢 Today's Press Release Bulletin from Medianet 🔢
www.linkedin.com/pulse/press-...
#Superannuation #ConsumerProtection #ClimateChange #Healthcare #BreastCancerResearch #AusArtDay #SupportTheArts #pressrelease #pressreleasedistribution #australia #australianews #media #journalists
www.linkedin.com/pulse/press-...
#Superannuation #ConsumerProtection #ClimateChange #Healthcare #BreastCancerResearch #AusArtDay #SupportTheArts #pressrelease #pressreleasedistribution #australia #australianews #media #journalists
Press Release Bulletin | 22 October 2026
Welcome to Medianet’s daily media alert featuring a curated list of today's most newsworthy press releases handpicked by our editorial team. Today's highlights PJCIS calls for people affected by radic...
www.linkedin.com
October 22, 2026 at 5:53 AM
🔢 Today's Press Release Bulletin from Medianet 🔢
www.linkedin.com/pulse/press-...
#Superannuation #ConsumerProtection #ClimateChange #Healthcare #BreastCancerResearch #AusArtDay #SupportTheArts #pressrelease #pressreleasedistribution #australia #australianews #media #journalists
www.linkedin.com/pulse/press-...
#Superannuation #ConsumerProtection #ClimateChange #Healthcare #BreastCancerResearch #AusArtDay #SupportTheArts #pressrelease #pressreleasedistribution #australia #australianews #media #journalists
Día Mundial del Cáncer de Mama: el #CNIO investiga cómo ajustar la prevención al riesgo de cada mujer y explorar terapias personalizadas, de #MamoRisk al triple negativo.
www.cnio.es/noticias/por...
#DíaMundialDelCáncerDeMama #BreastCancerResearch
www.cnio.es/noticias/por...
#DíaMundialDelCáncerDeMama #BreastCancerResearch
October 19, 2026 at 12:27 PM
Día Mundial del Cáncer de Mama: el #CNIO investiga cómo ajustar la prevención al riesgo de cada mujer y explorar terapias personalizadas, de #MamoRisk al triple negativo.
www.cnio.es/noticias/por...
#DíaMundialDelCáncerDeMama #BreastCancerResearch
www.cnio.es/noticias/por...
#DíaMundialDelCáncerDeMama #BreastCancerResearch
Learn more: lnkd.in/emCEijSd
Access Aurora Direct: www.auroraomics.org/log-in
#BreastCancerAwarenessMonth #BreastCancerResearch #SpatialTranscriptomics
#DigitalPathology
Access Aurora Direct: www.auroraomics.org/log-in
#BreastCancerAwarenessMonth #BreastCancerResearch #SpatialTranscriptomics
#DigitalPathology
LinkedIn
This link will take you to a page that’s not on LinkedIn
lnkd.in
October 20, 2026 at 6:51 AM
Learn more: lnkd.in/emCEijSd
Access Aurora Direct: www.auroraomics.org/log-in
#BreastCancerAwarenessMonth #BreastCancerResearch #SpatialTranscriptomics
#DigitalPathology
Access Aurora Direct: www.auroraomics.org/log-in
#BreastCancerAwarenessMonth #BreastCancerResearch #SpatialTranscriptomics
#DigitalPathology
Una semana de radioterapia, la nueva apuesta frente al cáncer de mama #DiaMundialDelCancerDeMama #diamundialcontraelcancerdemama #BreastCancerResearch www.larazon.es/salud/semana...
Una semana de radioterapia, la nueva apuesta frente al cáncer de mama
Oncólogos defienden que el tratamiento de irradiación en cinco sesiones ofrece eficacia y seguridad en pacientes seleccionadas
www.larazon.es
October 19, 2026 at 1:07 PM
Una semana de radioterapia, la nueva apuesta frente al cáncer de mama #DiaMundialDelCancerDeMama #diamundialcontraelcancerdemama #BreastCancerResearch www.larazon.es/salud/semana...
New Breast Cancer Treatments Offer More Personalized Options for Patients in 2026 #BreastCancerResearch #CancerTreatment #McAllenTexas #MegaDoctorNews #PrecisionOncology #RioGrandeValley #TexasBorderBusiness #TexasOncology
New Breast Cancer Treatments Offer More Personalized Options for Patients in 2026
Advances in genetic testing and clinical research are giving physicians new ways to select breast cancer treatments based on individual patients’ needs, according to Dr. Joseph Murray, senior medical director at Caris Life Sciences
megadoctornews.com
October 20, 2026 at 10:01 AM
New Breast Cancer Treatments Offer More Personalized Options for Patients in 2026 #BreastCancerResearch #CancerTreatment #McAllenTexas #MegaDoctorNews #PrecisionOncology #RioGrandeValley #TexasBorderBusiness #TexasOncology
In this work,we introduce m3DinAI Drug Quest,a high-content imaging platform that combines 3D tumor spheroids with label-free, longitudinal morphological profiling to characterize drug responses in triple-negative breast cancer
#WorldBreastCancerDay @medinadiscovery.bsky.social #BreastCancerResearch
#WorldBreastCancerDay @medinadiscovery.bsky.social #BreastCancerResearch
October 19, 2026 at 9:53 AM
In this work,we introduce m3DinAI Drug Quest,a high-content imaging platform that combines 3D tumor spheroids with label-free, longitudinal morphological profiling to characterize drug responses in triple-negative breast cancer
#WorldBreastCancerDay @medinadiscovery.bsky.social #BreastCancerResearch
#WorldBreastCancerDay @medinadiscovery.bsky.social #BreastCancerResearch
Had my first in-depth conversation with a breast cancer patient advocate this morning … one of the best scientific conversations I’ve ever had! #breastcancerresearch
October 16, 2026 at 3:21 PM
Had my first in-depth conversation with a breast cancer patient advocate this morning … one of the best scientific conversations I’ve ever had! #breastcancerresearch
🩷 Early detection saves lives.
On #NationalMammographyDay, we’re highlighting how lipidomics is helping researchers uncover the complex relationship between lipid metabolism and breast cancer. 🎀
Read the review: buff.ly/FmQ89VZ
#BreastCancerAwareness #Lipidomics #BreastCancerResearch #Biomarkers
On #NationalMammographyDay, we’re highlighting how lipidomics is helping researchers uncover the complex relationship between lipid metabolism and breast cancer. 🎀
Read the review: buff.ly/FmQ89VZ
#BreastCancerAwareness #Lipidomics #BreastCancerResearch #Biomarkers
October 16, 2026 at 6:30 AM
🩷 Early detection saves lives.
On #NationalMammographyDay, we’re highlighting how lipidomics is helping researchers uncover the complex relationship between lipid metabolism and breast cancer. 🎀
Read the review: buff.ly/FmQ89VZ
#BreastCancerAwareness #Lipidomics #BreastCancerResearch #Biomarkers
On #NationalMammographyDay, we’re highlighting how lipidomics is helping researchers uncover the complex relationship between lipid metabolism and breast cancer. 🎀
Read the review: buff.ly/FmQ89VZ
#BreastCancerAwareness #Lipidomics #BreastCancerResearch #Biomarkers
Continuous research drives real progress in cancer care.
U.S. Food and Drug Administration approved Tucatinib maintenance for advanced HER2+ breast cancer delayed cancer progression by a median 8.6 months in clinical trials.
#BreastCancerResearch #ClinicalTrials
https://ow.ly/u5x150ZXFGY
U.S. Food and Drug Administration approved Tucatinib maintenance for advanced HER2+ breast cancer delayed cancer progression by a median 8.6 months in clinical trials.
#BreastCancerResearch #ClinicalTrials
https://ow.ly/u5x150ZXFGY
October 15, 2026 at 3:58 PM
Continuous research drives real progress in cancer care.
U.S. Food and Drug Administration approved Tucatinib maintenance for advanced HER2+ breast cancer delayed cancer progression by a median 8.6 months in clinical trials.
#BreastCancerResearch #ClinicalTrials
https://ow.ly/u5x150ZXFGY
U.S. Food and Drug Administration approved Tucatinib maintenance for advanced HER2+ breast cancer delayed cancer progression by a median 8.6 months in clinical trials.
#BreastCancerResearch #ClinicalTrials
https://ow.ly/u5x150ZXFGY
Continuous research drives real progress in cancer care.
U.S. Food and Drug Administration approved Tucatinib maintenance for advanced HER2+ breast cancer delayed cancer progression by a median 8.6 months in clinical trials.
#BreastCancerResearch #ClinicalTrials
https://ow.ly/u5x150ZXFGY
U.S. Food and Drug Administration approved Tucatinib maintenance for advanced HER2+ breast cancer delayed cancer progression by a median 8.6 months in clinical trials.
#BreastCancerResearch #ClinicalTrials
https://ow.ly/u5x150ZXFGY
October 14, 2026 at 3:28 PM
Continuous research drives real progress in cancer care.
U.S. Food and Drug Administration approved Tucatinib maintenance for advanced HER2+ breast cancer delayed cancer progression by a median 8.6 months in clinical trials.
#BreastCancerResearch #ClinicalTrials
https://ow.ly/u5x150ZXFGY
U.S. Food and Drug Administration approved Tucatinib maintenance for advanced HER2+ breast cancer delayed cancer progression by a median 8.6 months in clinical trials.
#BreastCancerResearch #ClinicalTrials
https://ow.ly/u5x150ZXFGY
Another reminder this is still going on, I've also added Headshots & Busts (commission spots I don't really offer unless you get a custom) for $15 and $40 accordingly!
Only 11 days left, click the link in the OP!
#breastcancerawareness #breastcancerresearch #fundraiser
Only 11 days left, click the link in the OP!
#breastcancerawareness #breastcancerresearch #fundraiser
TILTIFY LINK for Breast Cancer Awareness YCH
tilt.fyi/yHWWyIvLCD
tilt.fyi/yHWWyIvLCD
October 13, 2026 at 12:26 PM
Another reminder this is still going on, I've also added Headshots & Busts (commission spots I don't really offer unless you get a custom) for $15 and $40 accordingly!
Only 11 days left, click the link in the OP!
#breastcancerawareness #breastcancerresearch #fundraiser
Only 11 days left, click the link in the OP!
#breastcancerawareness #breastcancerresearch #fundraiser
